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Prevalence and correlates of psychological distress among drug users1
in Phnom Penh, Cambodia2
3
ABSTRACT4
Background: Compared to the general population, drug users are at increased risk of 5
both poor mental health and HIV infection. The aim of this study was to determine 6
the prevalence and correlates of high psychological distress among drug users in 7
Cambodia.8
Methods: In April 2014, a two-stage cluster sampling method was used to randomly 9
select 169 drug users from hotspots in Phnom Penh. Psychological distress was 10
measured using General Health Questionnaire (GHQ-12). Bivariate and multivariable 11
analyses were conducted to identify factors associated with levels of psychological 12
distress among this population.13
Results: Our study found high prevalence of attempted suicide (15.3%), drug related 14
arrests (46.2%), and incarceration (31.4%). Of the 169 participants, 42.0% were found 15
to have high levels of psychological distress, indicating poor mental health. After 16
adjustment, high levels of psychological distress were independently associated with 17
suicidal ideation (p< 0.001), higher frequency of drug use (p= 0.02), sharing of 18
needles or syringes (p= 0.005), and having been sent to a rehabilitation centre (p= 19
0.02). In addition, participants who perceived their overall health as being poor or 20
very poor were more likely to have high levels of psychological distress (p= 0.002).21
Conclusions: Integration of mental health within HIV and needle and syringe 22
exchange programmes is required to address psychological distress among drug users 23
in Cambodia. Health system interventions, such as screening, referral, and training of 24
health providers, need to be strengthened. In addition, interventions addressing social 25










determinants of mental health and mitigation of frequent arrests and improving26
conditions in rehabilitation centres are required.27
28
Keywords: Mental health; Drug use; HIV; Harm reduction; Integration; Cambodia 29
30
Introduction31
Poor mental health is a source of significant public health burden globally32
(Whiteford et al., 2013). In 2010, mental health was the 11th most important cause of 33
morbidity and mortality globally (Murray et al., 2012). Mental health conditions are 34
also among the most difficult to treat (Stein & Seedat, 2007). In many contexts, 35
people with severe mental disorders are also the most vulnerable and socially 36
excluded (Funk, Drew, Freeman, & Edwige, 2010). Although prevalence of poor 37
mental health differs by contexts and sensitivity of screening methods (Charlson, 38
Diminic, Lund, Degenhardt, & Whiteford, 2014), evidence suggests that, compared to 39
the general population, drug users are more likely to have mental disorders40
(Armstrong, et al., 2013; Brienza et al., 2000; Conner, Pinquart, & Duberstein, 2008; 41
Knowlton et al., 2001).42
Research has shown that the relationship between mental disorders and drug 43
use is complex and either can proceed, reinforce, or be the consequence of the other44
(Buckingham, Schrage, & Cournos, 2013). Drug use is often a behavioural 45
mechanism for coping with mental health symptoms (Loue, Sajatovic, & Mendez, 46
2011). While understanding the causation sequence remains relevant, evidence47
suggest that severity of poor mental health is often correlated with the extent of drug 48
dependence, unmet service needs (Li et al., 2015), and in some cases, adverse 49
childhood experiences (Kang, Deren, & Goldstein, 2002) of drug users. In addition, 50










while the direction of the effect may differ, gender is also an important mediator of 51
the way in which poor mental health is experienced or coped with among this 52
population (Loue et al., 2011; Pettes et al., 2015; Shaw et al., 2015; Springer, Chen, & 53
Altice, 2009).54
HIV is often overlaid within this complex situation: poor mental health,55
particularly depression, is often linked with an increased uptake of high-risk 56
behaviours and ultimately, HIV infection among drug users. Various studies have 57
shown that drug users with severe depressive symptoms and suicidal thoughts are 58
more likely to share needles and syringes (Armstrong, Jorm, et al., 2013; Mackesy-59
Amiti, Donenberg, & Ouellet, 2014). Those with severe depression and suicidal 60
thoughts have a greater frequency of unsafe drug injection (Li et al., 2013; Pilowsky, 61
Wu, Burchett, Blazer, & Ling, 2011), more sexual partners, and greater frequency of 62
unprotected sex (Armstrong, Jorm, et al., 2013; Pettes et al., 2015).63
Once infected with HIV, poor mental health can lead to poor treatment 64
outcomes among drug users, including poor adherence to antiretroviral therapy65
(Carrieri et al., 2003; Palmer, Salcedo, Miller, Winiarski, & Arno, 2003), faster 66
disease progression (Bouhnik et al., 2005), and increased hospitalisation (Marimoutou 67
et al., 2003). In addition, improvement in mental health has been noted following 68
initiation of antiretroviral therapy among drug users. Standard interventions in HIV 69
treatment, such as motivational counselling, adherence counselling, peer-based 70
support, and case management, often have a positive psychological impact, which in 71
turn reduces substance use (Springer et al., 2009). These observations suggest that 72
better linkages between mental health, HIV prevention and treatment, and needle-73
exchange programmes could be beneficial.74










In particular, it is important to identify how the already defined packages of 75
mental health services (Patel & Thornicroft, 2009) can be delivered to drug users in 76
low- and middle-income countries. In countries such as Cambodia, limited progress 77
has been made in the understanding patterns of mental health among this population. 78
In response to this gap, this paper documents the prevalence and correlates of high 79
psychological distress among drug users in Phnom Penh, Cambodia.80
81
Methods82
Study sites, sampling and training83
In April 2014, data used for this study were collected as part of an impact 84
evaluation of the Sustainable Action against HIV and AIDS in Communities 85
(SAHACOM) project implemented by KHANA, the largest national non-86
governmental organisation providing integrated HIV prevention, care, and support 87
services at the community level in Cambodia. The details of the SAHACOM project 88
have been published elsewhere (Yi, Chhoun, Brant, Kita, & Tuot, 2014; Yi et al., 89
2015). The study participants were randomly selected for face-to-face interviews from 90
a list of hotspots obtained from KHANA’s partners who implemented the 91
SAHACOM programm s in the capital city of Phnom Penh. 92
A two-stage cluster sampling method was used to select the study sample. At 93
the first stage, the probability proportional-to-size sampling method was used to select 94
hotspots from the list. At the second stage, because of the small number of reachable 95
participants who use drugs in the programmes, all drug using clients in the selected 96
hotspots were invited to participate in the study. A person would be included in the 97
study if they: (1) were at least 18 years of age; (2) had used any form of illicit drugs in 98










the past three months; (3) were able to present themselves on the day of the interview;99
and (4) were able to provide informed consent to participate in the study. 100
All research team members were trained for three days on the study methods, 101
interview techniques, privacy assurance, and confidentiality. The training also 102
addressed quality control strategies, such as rechecking and reviewing the 103
questionnaires after administration and resolving issues that might arise during the 104
fieldwork. Data collection team leaders were encouraged to perform regular reviews 105
on the progress of the data collection and communicate any issues that may occur 106
during the data collection.107
108
Questionnaire development and measurements 109
A structured questionnaire was first developed in English and then translated 110
into Khmer, the national language of Cambodia. The Khmer questionnaire was back-111
translated and pretested with a sample of 10 drug users to ensure that wording and 112
contents were culturally suitable and clearly understandable for the respondents. We 113
also received comments from experts working on HIV and mental health in key 114
populations in Cambodia and the questionnaire was finalised based on their feedbacks115
and findings from the pilot phase.116
Standardised tools were adapted from previous studies in the same population 117
(Heng & Tuot, 2013), the most recent Cambodia Demographic and Health Survey 118
(National Institute of Public Health National Institute of Statistics and ORC Macro, 119
2010) as well as from other studies in Cambodia (Yi et al., 2010). Socio-demographic 120
characteristics included age, marital status, completed years of formal education, 121
average monthly income, and living situations. In addition, we also collected 122
information on self-perception of level of HIV risk compared to the general 123










population, self-rated overall health and quality of life, suicidal thoughts and suicide124
attempts in the past three months.125
Regarding illicit drug use, participants were questioned about types of illicit 126
drugs and frequency of use in the past three months, duration since the first use and 127
age at the first use. For those who reported injecting drugs, they were also asked 128
whether they had used needles or syringes that had been used by someone else in the 129
past three months. In addition, respondents were questioned about whether they had 130
been arrested because of drugs-related acts, sent to a rehabilitation centre, or131
incarcerated. These rehabilitation centres are community-based treatment centres that 132
are meant to provide care and treatment services (including access to HIV prevention, 133
treatment, and care resources), as well as vocational training for drug users.134
Adverse childhood experiences were measured using five questions adapted 135
from the brief screening version of the Childhood Trauma Questionnaire (Bernstein et 136
al., 2003). The questions collected information on the experience of physical abuse, 137
emotional abuse, sexual abuse, physical neglect, and emotional neglect with five 138
response options ranging from (1) ‘never’ to (5) ‘very often’. Participants who 139
responded ‘never’ or ‘rarely’ were grouped together as those without adverse 140
childhood experiences and those who answered ‘sometimes’, ‘often’, or ‘very often’ 141
as those with adverse childhood experiences.142
We also adapted five items from the brief screening version of the Childhood 143
Trauma Questionnaire to enquire about family dysfunction (Bernstein, Ahluvalia, 144
Pogge, & Handelsman, 1997; Bernstein et al., 2003). The items collected information 145
on ‘witnessing violence against a family member’, ‘having an alcoholic or drug user 146
family member’, ‘having a family member who was depressed, mentally ill, or who 147
has attempted suicide’, ‘having parents who had been separated or divorced’, and 148










‘having a family member who has been to prison’. The response options for all the 149
items were ‘yes’ or ‘no,’ except for ‘having parents who had been separated or 150
divorced’. For this item, another response option was added to indicate if one or both 151
parents had died. In the analysis, participants whose parents had divorced or separated 152
were grouped together with participants whose parent(s) had died.153
Psychological distress was measured using a short version of the General 154
Health Questionnaire (GHQ-12) (Goldberg, 1972), which has been validated in Asian 155
populations (Zulkefly & Baharudin, 2010). Each item was rated on a four-point 156
Likert-like scale ranging from “0= less than usual” to “3= much more than usual”.157
The scoring method ‘0-0-1-1’ was used as it is believed to help eliminate biases 158
resulted from respondents who tend to choose responses 0 and 3 or 1 and 2 (Goldberg 159
& Williams, 1988). The mean score for the whole study population (GHQ-12= 3) was 160
used as a cut-off to define lower and higher levels of psychological distress as it 161
provides the best threshold for discriminating those with psychological distress from 162
those without, especially considering documented variation of GHQ scores from place 163
to place (Goldberg, Oldehinkel, & Ormel, 1998). Using the mean as a threshold is 164
consistent with previous cut offs (Brody et al., 2016). The Cronbach’s alpha among 165
participants in this study was 0.78.166
167
Data analyses168
Double data entry was performed using EpiData version 3 (Odense, 169
Denmark). In bivariate analyses, we used χ2 test, or Fisher’s exact test when sample 170
sizes were smaller than five in one cell, for categorical variables. Student’s t-test was 171
used for continuous variables to compare socio-demographic characteristics, self-172
rated overall health and quality of life, history of illicit drug use, and adverse 173










childhood experiences among participants who had a lower level of psychological 174
distress (GHQ-12≤ 3) to those among participants who had a higher level of 175
psychological distress (GHQ-12> 3). 176
A multivariable logistic regression model was then constructed to control for 177
the effects of potential confounding factors. We included age, gender, and all 178
variables associated with psychological distress in bivariate analyses at a level of p< 179
0.05 in the model. Adjusted odds ratio (AOR) were obtained and presented with 95% 180
confidence intervals (CI) and p-values. SPSS version 22 (IBM Corporation, New 181
York, USA) was used for all statistical analyses.182
183
Ethical statement184
The National Ethics Committee for Health Research of the Ministry of Health, 185
Cambodia approved this study (Reference no. 082NECHR). A written informed 186
consent was obtained from each participant after it was made clear that participation 187
in this study was voluntary and that they could refuse or discontinue their 188
participation at any time. We protected privacy of the respondents by conducting the 189
interviews at a private place and no personal identifiers were collected in the 190




A total of 169 drug users participated in the study with a mean age of 31.1 195
(SD= 6.3); of whom 76.9% were male, 42.6% were married or cohabiting, 32.5% 196
were self-employed, and 79.8% had been tested for HIV in the six months preceding 197
the study. The majority (58.9%) of the respondents thought that their HIV risk was 198










either the same or lower than that of the general population. More than two-thirds 199
(69.9%) of the respondents reported that their overall health was either poor, very 200
poor, or neither good nor poor, and 77.6% reported that their overall quality of life 201
was either poor, very poor, or neither good nor poor.  Over a quarter (26.6%) reported 202




Approximately a half (47.6%) of the respondents reported using any illicit 207
drug on a daily basis. In regard to patterns of drug use, 65.1% reported using208
methamphetamine, 35.5% reported using heroin, and 34.3% reported injecting drugs209
in the three months preceding the study. Of those who injected drugs, 24.6% reported 210
sharing needles or syringes in the past three months. Of total, 19.5% of the 211
participants reported having been sent to a rehabilitation centre in the past 12 months, 212
46.2% reported having been arrested in relation to drug acts in their life time, and213
31.4% reported having been incarcerated in their lifetime (Table 2).214
215
Characteristics related to adverse childhood experiences216
A significant number of respondents reported having been physically hurt that 217
needed medical care (61.7%) or that a family member had said hurtful or insulting 218
things to them (66.5%) when they were growing up. More than half (52.1%) came 219
from families in which parents had been separated or divorced. In addition, 43.7% 220
reported that a parent or guardian had been physically abused, while 38.3% reported 221
having a family member who was a problem drinker or a drug user, and 31.1% 222










reported that a family member had been to prison when they were growing up (Table 223
3). 224
225
Bivariate results of factors associated with psychological distress226
In total, 42.0% were found to have high levels of psychological distress, 227
indicating poor mental health. As shown Table 1, a high level of psychological 228
distress was significantly associated with self-perception of poor overall health (p< 229
0.001), self-perception of poor quality of life (p= 0.01), suicidal ideation (p< 0.001), 230
and suicide attempts (p= 0.02). Table 2 shows that a higher level of psychological 231
distress was significantly associated with frequency of illicit drug use (p= 0.04), 232
methamphetamine use (p< 0.001), younger age at first use of illicit drugs (p= 0.005), 233
sharing of needles or syringes in the past three months (p= 0.001), having been sent to 234
a rehabilitation centre in the past 12 months (p= 0.005), and having been incarcerated 235
in lifetime (p= 0.04). Further analysis of factors associated with higher level of 236
psychological distress was conducted in relation to adverse childhood experiences. 237
Table 3 shows that higher level of psychological distress was significantly associated 238
with having a family member who said hurtful or insulting things to them (p= 0.03) or 239
who had been to prison (p= 0.005). 240
241
Factors independently associated with psychological distress242
The results of multivariate analysis are shown in Table 4. After controlling for 243
potential confounders, elevated levels of psychological distress remained significantly 244
associated with perception of poor overall health condition (AOR= 9.60, 95% CI= 245
2.36-8.99), having suicidal ideation (AOR= 6.30, 95% CI= 1.93-10.60), higher 246
frequency of drug use in the past 3 months (AOR= 0.32, 95% CI= 0.13-0.82), having 247










shared needles or syringes in the past three months (AOR= 5.55, 95% CI= 2.34-248
13.38), and having been sent to a rehabilitation centre in the past 12 months (AOR= 249




We set out to describe the prevalence of psychological distress among drug 254
users in Cambodia and factors that are associated with it. Our main results show that 255
42% of participants in this study had a high level of psychological distress, indicating256
poor mental health, based on pre-specified GHQ-12 based criteria. These findings 257
support observations from other contexts showing high prevalence of various forms of 258
mental health disorders among drug users. In their 2013 study conducted in India, 259
Armstrong et al found very high prevalence of depressive symptoms (84%), anxiety 260
(71%), and suicidal ideation (36%) in their drug using study participants. In the 261
United States, a study of 528 drug users found that 54% of those in needle exchange 262
programmes and 42% of those in methadone maintenance therapy had major 263
depression (Brienza et al., 2000). Overall, evidence from systematic reviews and 264
longitudinal studies suggests that depression, antisocial personality disorders, 265
alcoholism, and suicidal ideation are particularly common among drug users (Conner 266
et al., 2008; Knowlton et al., 2001). 267
In addition, our study demonstrates that high levels of psychological distress 268
are independently linked to perception of poor overall health, drug use frequency, 269
suicidal ideation, sharing of needles or syringes, and having been sent to a 270
rehabilitation centre.  These results support findings from other studies suggesting 271
that psychological distress is often associated with suicidal ideation (Armstrong et al., 272










2014; Bell, Russ, Kivimaki, Stamatakis, & Batty, 2015) and risky behaviours273
involving injecting drugs (Stein, Solomon, Herman, Anderson, & Miller, 2003).274
It may seem counterintuitive that having been sent to a drug rehabilitation 275
centre is associated with higher levels of psychological distress. However, across 276
Asia, including Cambodia, these compulsory rehabilitation centers have found to limit 277
access to HIV and wider healthcare (Kamarulzaman & McBrayer, 2015), and violate 278
basic human rights (Amon, Pearshouse, Cohen, & Schleifer, 2013) of drug users. In 279
some instances, patients are forced into labor and physically, and sometimes sexually280
abused (Amon et al., 2013). Although not directly predictive of high levels of 281
psychological stress, our study also found high prevalence of suicide attempts (15%), 282
drug related arrests (46%), incarceration (31%), and a history of physical (61%) and 283
psychological (67%) abuse during childhood. The high prevalence of psychological 284
distress should be interpreted within a wider context in which psychiatric symptoms 285
among older populations exposed to past traumatic events are also common (Dubois 286
et al., 2004). 287
288
Improving mental health among drug users289
Based on the findings of our and other studies, we suggest that a combination 290
of interventions that strengthen systems to deliver appropriately integrated 291
interventions to improve the social determinants of poor mental health among drug 292
users are needed.293
294
Health systems strengthening model295
In particular, these findings have important implications for ensuring that drug 296
users are screened and referred to preventive and therapeutic mental health 297










interventions. In addition, better linkage between harm reduction, especially needle 298
and syringe exchange programmes, with both HIV and mental health services is 299
required. This means that screening of mental health symptoms ought to happen 300
regularly within HIV and harm reduction services. Conversely, regular HIV testing 301
among recipients of mental health and incarcerated drug users is required, given the 302
link between poor mental health and HIV risk (Stockman & Strathdee, 2010). 303
Training of existing health providers on these issues (Charlson et al., 2014; 304
Mendenhall et al., 2014), as well as task shifting of mental health screening to non-305
clinicians (McInnis & Merajver, 2011) and other innovative models (Eaton et al., 306
2011) may be required in Cambodia and other resource-poor settings.307
The limitation of this model is that mental health care is poorly developed in 308
low- and middle-income countries and is currently being confronted by lack of 309
prioritisation, scarcity of human and financial resources, and difficulties in finding 310
innovative public mental health programmes that can be scaled up (Eaton et al., 311
2011). A recent survey showed that more than 75% of those identified with serious 312
anxiety, mood, or substance use disorders in low- and middle-income countries 313
received no care at all (Demyttenaere et al., 2004). As such, a pragmatic short-term 314
goal could be to train health providers in the relatively developed HIV and harm 315
reduction programmes to screen and prevent poor mental health outcomes, while at 316
the same time increasing investments to strengthen mental health services in the long317
term. Studies suggest that peer and motivational counseling available in HIV and 318
harm reduction programmes have a positive effect on mental health outcomes319
(Springer et al., 2009), and therefore adapting these pre-existing services could be a 320
realistic short-term approach. Finally, emphasis on local policies and guidelines is 321










required. Although global recommendations related to mental health exist, 322
implementation is lacking (Stein & Seedat, 2007).323
324
Social determinants model 325
A fundamental argument for a social ecological model is that a significant 326
proportion of psychological distress and other mental health symptoms can be 327
improved by addressing social determinants of poor mental health (Fisher & Baum, 328
2010). In relation to drug users, these interventions include creating awareness 329
(Armstrong & Samson, 2016), mental health promotion, social protection, livelihood, 330
employment, and psychosocial support (Amirkhanian, Kelly, & McAuliffe, 2003) at 331
the community level. In addition, strengthening the collaboration between mental 332
health outreach teams and police departments (Girard et al., 2014) can mitigate some 333
systemic and structural factors that cause or exacerbate mental distress such as 334
frequent arrests and incarceration. The long-term goal should be to move from 335
institutional to family-centered and community-based mental health services (Tomori 336
et al., 2014), and in this context, outside of rehabilitation centers. Our findings 337
demonstrate a clear link between past treatment at rehabilitation centers and higher 338
levels of psychological distress. Previous commentators have called for a shift 339
towards human and evidence-based treatment of drug users (Amon et al., 2013; Csete 340
et al., 2011). As such, these “rehabilitation” centres should be re-evaluated.341
Interventions should also be gender sensitive, targeting individuals as well as others 342
within their family and social networks (Kermode, Songput, Sono, Jamir, & Devine, 343
2012; Loue et al., 2011). This is particularly relevant in Cambodia given that majority 344
(59%) of participants in our study thought that their HIV risk was either the same or 345
lower than that of the general population, emphasising the need for greater health 346










awareness and empowerment of drug users in the study context. At the same time, 347
creating systems that respond to adverse childhood experiences, such as physical and 348
psychological abuse and neglect, may also reduce incidence of drug use (Macleod et 349
al., 2013) as well as poor mental health in this and other populations (De Venter, 350
Demyttenaere, & Bruffaerts, 2013).351
352
Implications for HIV Programmes353
These models and interventions have specific relevance to HIV prevention. 354
Our findings indicate that individuals in distress are more than five times more likely 355
to report recently sharing used syringes but less likely to inject drugs daily. Other 356
studies have also shown that drug users have a greater frequency of unsafe drug 357
injection if they are facing mental health difficulties (Li et al., 2013; Pilowsky et al., 358
2011). Given the link between unsafe drug injecting and HIV transmission, a nuanced 359
approach of integrating mental health screening in HIV prevention and needle syringe 360
exchange programmes could be beneficial. In Cambodia, HIV service providers 361
should be trained to screen for psychological distress and other mental health 362
symptoms among those accessing HIV testing in keeping with the heath systems 363
strengthening model. This approach has been successfully implemented in Ethiopia364
(Wissow et al., 2015). At the community level, peer-based outreach, needle exchange 365
and community-based support groups should be expanded to include screening and 366
psychosocial support for those identified with psychological distress, in keeping with 367
the social determinant model. This approach has also been successfully implemented 368
within Hepatitis C programmes in Australia (Norman et al., 2008). In the Cambodian369
context, cultural sensitivity of mental health interventions (Armstrong & Samson, 370










2016) is critical, given the history of mass violence, trauma, and genocide (Dubois et 371
al., 2004; Mollica, Brooks, Tor, Lopes-Cardozo, & Silove, 2014).372
373
Limitations of the study374
Data were collected only from participants in the capital city where the 375
SAHACOM, a comprehensive community-based project aiming to improve health 376
and quality of life of key populations, has been implemented. Because the 377
SAHACOM focuses on these key populations, including drug users, participants had 378
an existing link to prevention and care services. The levels of risks and outcomes 379
reported in this study may therefore represent a more optimistic view than in other 380
areas of Cambodia. Due to the cross-sectional design of the study, causal inferences 381
were not possible. Our study was designed to identify prevalence among drug users382
without a priori hypothesis. Because we were uncertain of how many participants we 383
would reach, a prior sample size was not determined. In the end, all drug users 384
identified at hot spots were invited to participate. All measures were self-reported, 385
which could have been influenced by social desirability and recall bias. However, 386
efforts were made to reduce these biases, including the study procedures that ensured 387
confidentiality and privacy. Finally, the use of the mean score of the GHQ-12 as the 388
cut-point (GHQ-12> 3) for higher levels of psychological distress could have 389
underestimated the prevalence of psychological distress. GHQ-12 scores can vary 390
from one place to another (Goldberg et al., 1998). However, in the absence of studies 391
assessing psychological distress among the general populations using the same scale, 392
we used this cut off based on our previous (Brody et al., 2016) and ongoing (Yi et al., 393
2016) studies.394
395











This study shows that suicidal ideation, sharing of needles or syringes, and 397
being sent to a rehabilitation centre are independently predictive of elevated levels of 398
psychological distress. We suggest that a combination of health systems strengthening 399
that involves screening, referral, and training of health providers, as well as 400
addressing social determinants of mental health symptoms that involves mental health 401
promotion, social protection, livelihood support, employment support, and mitigation 402
of frequent arrests and incarceration is needed. In addition, integration of mental 403
health with HIV, as well as needles and syringe exchange programmes, is needed. To 404
this end, developing and implementing policies and guidelines at the national level 405
will be required.406
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(n= 169) ≤ 3 (n= 98) > 3 (n= 71) p-value*
Mean age (in year) 31.1 ± 6.3 31.7 ± 6.6 30.2 ± 5.6 0.12
Gender 0.38
Male 130 (76.9) 73 (74.5) 57 (80.3)
Female   39 (23.1) 25 (25.5) 19 (19.7)
Years of formal education completed  5.2 ± 4.1 5.3 ± 4.2 5.1 ± 3.8 0.67
Marital status 0.57
Never married   65 (38.5) 38 (38.8) 27 (38.0)
Married and living together   72 (42.6) 44 (44.9) 28 (39.4)
Divorced/separated/widowed   32 (18.9) 16 (16.3) 16 (22.5)
Main occupation 0.26
Unemployed   23 (13.6) 10 (10.2) 13 (18.3)
Self-employed   55 (32.5) 32 (32.7) 23 (32.4)
Farmer/laborer   38 (22.5) 25 (25.5) 13 (18.3)
Office worker   10 (5.9)   8 (8.2)   2 (2.8)
Other   43 (25.4) 23 (23.5) 20 (28.2)
Average monthly income (in USD) 340 ± 586 340 ± 621 280 ± 540 0.51
Tested for HIV in the past 6 months 130 (79.8) 76 (80.0) 54 (79.4) 0.93
Self-perception of HIV risk compared to the general population 0.99
Higher   61 (37.4) 35 (37.6) 26 (37.1)
Same   21 (12.9) 12 (12.9)   9 (12.9)
Lower   75 (46.0) 43 (46.2) 32 (45.7)
Don’t know     6 (3.7)   3 (3.2)   3 (4.3)
Self-rated overall health < 0.001










Good/very good   51 (30.2) 39 (39.8) 12 (16.9)
Neither good nor poor   78 (46.2) 47 (48.0) 31 (43.7)
Poor/very poor   40 (23.7) 12 (12.2) 28 (39.4)
Self-rated quality of life 0.01
Good/very good   38 (22.5) 29 (29.6)   9 (12.7)
Neither good nor poor 101 (59.8) 56 (57.1) 45 (63.4)
Poor/very poor   30 (17.8) 13 (13.3) 17 (23.9)
Suicuidal ideation (past 3 months)   45 (26.6) 15 (15.3) 30 (42.3) < 0.001
Suicide attempts (past 3 months)   25 (15.3)   9 (9.7) 16 (22.9) 0.02
Abbreviations: GHQ-12, 12-Item General Health Questionnaire.627
Values are number (%) for categorical variables and mean ± SD for continuous variables.628
*Chi-square test or Fisher’s exact test was used for categorical variables and Student’s t-test 629



























Table 2. Comparisons of illicit drug use and related history among drug users with a lower 647




(n= 169) ≤3 (n=98) >3 (n=71) p-value*
Frequency of illicit drugs in the past 3 months 0.04
Not everyday   87 (52.4) 48 (49.5) 39 (56.5)
Everyday   79 (47.6) 49 (50.5) 30 (43.5)
Methamphetamine use in the past 3 months 110 (65.1) 53 (54.1) 57 (80.3) <0.001
Heroin use in the past 3 months   60 (35.5) 36 (36.7) 24 (33.8) 0.69
Duration since first use of drugs (in months) 100.7±68.8 92.8±63.1 111.4±75.5 0.08
Age at the first use of illicit drugs 21.3±6.4 22.5±7.0 19.7±5.0 0.005
Injected drugs in the past 3 months   58 (34.3) 31 (31.6) 27 (38.0) 0.39
Used needles/syringes that had been used by 
someone else in the past 3 months
  14 (24.6)   2 (6.7) 12 (44.4) 0.001
Had been arrested because of drugs-related 
acts in lifetime
  78 (46.2) 40 (40.8) 38 (53.5) 0.10
Had been sent to a rehabilitation center in
past 12 months
  33 (19.5) 12 (12.2) 21 (29.6) 0.005
Duration of last time in rehabilitation center
(in months)
3.4 ± 3.6 2.2 ± 1.2 4.1 ± 4.3 0.15
Had been incarcerated in lifetime   53 (31.4) 25 (25.4) 28 (39.4) 0.04
Times being incarcerated 1.5 ± 0.7 1.6 ± 0.8 1.4 ± 0.6 0.29
Duration of last incarceration (in months) 14.8 ± 16.9 16.8±20.9 13.0±12.4 0.42
Abbreviations: GHQ-12, 12-Item General Health Questionnaire.649
Values are number (%) for categorical variables and mean ± SD for continuous variables.650















Table 3. Comparisons of adverse childhood experiences and family dysfunction among drug 656
users with lower and higher levels of psychological distress657
Total GHQ-12 scoreAdverse childhood experiences and family 
dysfunction 
Total
(n= 169) ≤3 (n= 98) >3 (n=71) p-value*
Adverse childhood experiences
Physically hurt that needed medical care 103 (61.7) 56 (57.7) 47 (67.1) 0.22
Family member said hurtful or insulting things to 111 (66.5) 58 (59.8) 53 (75.7) 0.03
Someone touched in a sexual way   51 (30.5) 29 (29.9) 22 (31.4) 0.83
Had someone to take care of or protect 164 (98.2) 95 (97.9) 69 (98.6) 0.76
Someone in family made me feel that I was loved 160 (95.8) 94 (96.9) 66 (94.3) 0.40
Family dysfunction
Parent or guardian had been physically abused   73 (43.7) 40 (41.2) 33 (47.1) 0.45
Family member was a problem drinker/drug user   64 (38.3) 33 (34.0) 31 (44.3) 0.18
Family member had been depressed/mentally ill   43 (25.7) 21 (21.6) 22 (31.4) 0.15
Parents ever been separated or divorced   87 (52.1) 48 (49.5) 39 (55.7) 0.43
Family member had been to prison   52 (31.1) 22 (22.7) 30 (42.9) 0.005
Abbreviations: GHQ-12, 12-Item General Health Questionnaire.658
Values are number (%).659





















Table 4. Factors associated with high levels of psychological distress among drug users in 671
multiple logistic regression model672
Total score of GHQ-12 > 3
Variable
AOR (95% CI) p-value*
Age 0.99 (0.91-1.08) 0.85
Gender
Male Reference
Female 0.35 (0.11-1.07) 0.07
Self-rated overall health
Good/very good Reference
Neither good nor poor 3.65 (1.07-12.42) 0.04
Poor/very poor 9.60 (2.36-8.99) 0.002
Self-rated quality of life
Good/very good Reference
Neither good nor poor 1.38 (0.41-4.65) 0.65
Poor/very poor 2.27 (0.53-9.76) 0.27
Having suicidal ideation in the past 3 months
No Reference
Yes 6.30 (1.93-10.60) 0.002
Having attempted suicide in the past 3 months
No Reference
Yes 0.39 (0.16-2.03) 0.36
Drug use frequency in the past 3 months
Not everyday Reference
Everyday 0.32 (0.13-0.82) 0.02
Used needles/syringes that had been used by someone else in the past 3 months
No Reference










Yes 5.55 (2.34-13.38) 0.005
Had been arrested because of drugs-related acts in lifetime
No Reference
Yes 0.64 (0.25-1.64) 0.35
Had been sent to a rehabilitation center in the past 12 months
No Reference
Yes 2.93 (1.12-8.72) 0.02
Had been incarcerated in lifetime
No Reference
Yes 1.54 (0.58-4.10) 0.39
Family member said hurtful or insulting things to when growing up
No Reference
Yes 0.32 (0.58-4.10) 0.82
Family member had been to prison
No Reference
Yes 1.55 (0.60-3.99) 0.37
Abbreviations: GHQ-12, 12-Item General Health Questionnaire.673
AOR, adjusted odds ratio; CI, confidence interval.674
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